About
Team
Portfolio
Insights
About
Team
Portfolio
Insights
Clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer.
Clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer.
Sectors
Healthcare
Life Sciences
First Invested
2017
Public/PIPES
Company Status
IPO/Acquired
NASDAQ/TSX: TRIL
Acquired by Pfizer
Associated Team
Ali Behbahani, MD
Paul Walker
Website
Trillium Therapeutics